A safer and more effective animal vaccine against Rift Valley Disease (RVD) first discovered in Kenya, could in the next one year be considered for use following successful field trials.
This mosquito-borne disease is prevalent in sub-Saharan Africa but research findings by Kenya Medical Research Institute (Kemri), Kenya Ministry of Agriculture Livestock and Fisheries, Centre for Disease Control and Prevention-Kenya show there is a promise of a safer livestock vaccine.